Norifumi Iseda

740 total citations
54 papers, 498 citations indexed

About

Norifumi Iseda is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Norifumi Iseda has authored 54 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 19 papers in Oncology and 17 papers in Hepatology. Recurrent topics in Norifumi Iseda's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Cancer, Lipids, and Metabolism (10 papers). Norifumi Iseda is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Cancer, Lipids, and Metabolism (10 papers). Norifumi Iseda collaborates with scholars based in Japan and United States. Norifumi Iseda's co-authors include Shinji Itoh, Tomoharu Yoshizumi, Takeo Toshima, Noboru Harada, Takahiro Tomiyama, Yoshinao Oda, Kyohei Yugawa, Masaki Mori, Akinari Morinaga and Kenichi Kohashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgery and Scientific Reports.

In The Last Decade

Norifumi Iseda

44 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norifumi Iseda Japan 13 180 171 159 147 125 54 498
Wei Gan China 13 140 0.8× 195 1.1× 86 0.5× 123 0.8× 138 1.1× 32 478
Xiaowei Dang China 12 123 0.7× 224 1.3× 165 1.0× 163 1.1× 92 0.7× 33 509
Yota Kawasaki Japan 14 156 0.9× 308 1.8× 190 1.2× 215 1.5× 223 1.8× 71 643
Tomonori Iida Japan 12 113 0.6× 293 1.7× 104 0.7× 128 0.9× 167 1.3× 37 576
Guo Long China 13 165 0.9× 170 1.0× 152 1.0× 213 1.4× 60 0.5× 26 492
Rongqiang Liu China 13 96 0.5× 196 1.1× 111 0.7× 109 0.7× 133 1.1× 52 480
Francesco Puleo Belgium 11 238 1.3× 476 2.8× 151 0.9× 181 1.2× 188 1.5× 19 668
Boyang Chang China 12 76 0.4× 224 1.3× 94 0.6× 142 1.0× 90 0.7× 26 458
Jin Gu China 11 93 0.5× 172 1.0× 85 0.5× 89 0.6× 96 0.8× 36 412

Countries citing papers authored by Norifumi Iseda

Since Specialization
Citations

This map shows the geographic impact of Norifumi Iseda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norifumi Iseda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norifumi Iseda more than expected).

Fields of papers citing papers by Norifumi Iseda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norifumi Iseda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norifumi Iseda. The network helps show where Norifumi Iseda may publish in the future.

Co-authorship network of co-authors of Norifumi Iseda

This figure shows the co-authorship network connecting the top 25 collaborators of Norifumi Iseda. A scholar is included among the top collaborators of Norifumi Iseda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norifumi Iseda. Norifumi Iseda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasui, Yumiko, Kôichi Kimura, Norifumi Iseda, et al.. (2025). Hilar Cholangiocarcinoma with Para-Aortic Lymph Node Metastasis Treated with Chemoimmunotherapy and Conversion Surgery: A Case Report. Surgical Case Reports. 11(1). n/a–n/a.
2.
Toshida, Katsuya, Shinji Itoh, Yuki Nakayama, et al.. (2025). Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 32(10). 8037–8045.
3.
Toshima, Takeo, Shinji Itoh, Yoshihiro Nagao, et al.. (2024). What is the crux of successful living‐donor liver transplantation for recipients aged 70 and beyond?. Annals of Gastroenterological Surgery. 8(4). 668–680.
4.
Ishikawa, Takuma, Shinji Itoh, Takeo Toshima, et al.. (2024). A successful case of deceased-donor liver transplantation from a donor with Marfan syndrome: a case report. SHILAP Revista de lepidopterología. 10(1). 14–14.
5.
Toshida, Katsuya, Shinji Itoh, Takeo Toshima, et al.. (2024). Association of serum lactate dehydrogenase with prognosis and tumor metabolism in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy. Surgery Today. 55(3). 370–379. 1 indexed citations
6.
Yoshiya, Shohei, Shinji Itoh, Takeo Toshima, et al.. (2024). Is preoperative weight reduction of living-donor liver transplant recipients and donors harmful to postoperative outcomes?. Journal of Gastrointestinal Surgery. 28(7). 1033–1038. 1 indexed citations
7.
Iguchi, Tomohiro, et al.. (2024). Utility of Pan-Immune-Inflammatory Value and Lactate for Determining Surgical Indications for Portal Venous Gas and Intestinal Pneumatosis. The Japanese Journal of Gastroenterological Surgery. 57(3). 101–108.
8.
Toshima, Takeo, et al.. (2024). Clinical validation of preoperative serum markers for liver fibrosis in living donor liver transplantation recipients. Surgery Today. 55(5). 627–637. 3 indexed citations
9.
Iguchi, Tomohiro, Norifumi Iseda, Noboru Harada, et al.. (2023). Development of predictive score for postoperative dysphagia after emergency abdominal surgery in patients of advanced age. Annals of Gastroenterological Surgery. 8(1). 172–181. 1 indexed citations
10.
11.
Tomiyama, Takahiro, Shinji Itoh, Norifumi Iseda, et al.. (2023). Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma. Annals of Surgical Oncology. 30(6). 3378–3389. 9 indexed citations
12.
Iguchi, Tomohiro, et al.. (2022). Delayed laparoscopic cholecystectomy for a patient with coronavirus disease 2019 who developed gangrenous cholecystitis: a case report. SHILAP Revista de lepidopterología. 8(1). 134–134. 1 indexed citations
13.
Iguchi, Tomohiro, Norifumi Iseda, Kazuki Takada, et al.. (2022). A case of successful conversion surgery for locally advanced pancreatic cancer with synchronous triple cancer of the lung and esophagus: a case report. SHILAP Revista de lepidopterología. 8(1). 19–19.
14.
Iguchi, Tomohiro, Takashi Motomura, Hideaki Uchiyama, et al.. (2021). Impact of a 7.5-Fr Pancreatic Stent for Preventing Pancreatic Fistula after Pancreaticoduodenectomy. Digestive Surgery. 38(5-6). 361–367. 4 indexed citations
15.
Iseda, Norifumi, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2021). Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status. Hepatology Communications. 6(4). 665–678. 14 indexed citations
16.
Itoh, Shinji, Tomoharu Yoshizumi, Yoshiyuki Kitamura, et al.. (2021). Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation. Hepatology Communications. 5(7). 1278–1289. 33 indexed citations
17.
Yugawa, Kyohei, Shinji Itoh, Norifumi Iseda, et al.. (2021). Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status. Scientific Reports. 11(1). 5845–5845. 18 indexed citations
18.
Yugawa, Kyohei, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2020). Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes. Modern Pathology. 34(4). 798–807. 43 indexed citations
19.
Shimokawa, Masahiro, Tomoharu Yoshizumi, Shinji Itoh, et al.. (2020). Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma. Cancer Science. 111(4). 1228–1240. 36 indexed citations
20.
Iseda, Norifumi, Shinji Itoh, Tomoharu Yoshizumi, et al.. (2020). ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma. Hepatology Communications. 5(4). 675–688. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Gan Breakdown of academic impact, for papers by Xiaowei Dang Breakdown of academic impact, for papers by Yota Kawasaki Breakdown of academic impact, for papers by Tomonori Iida Breakdown of academic impact, for papers by Guo Long Breakdown of academic impact, for papers by Rongqiang Liu Breakdown of academic impact, for papers by Francesco Puleo Breakdown of academic impact, for papers by Boyang Chang Breakdown of academic impact, for papers by Jin Gu
Rankless by CCL
2026